| Literature DB >> 29891925 |
Yan Yuan1,2, Yajing Zhang1,2, Shiwen Zhao1,2, Jie Chen1,2, Jinlong Yang1,2, Tao Wang1,2, Hui Zou1,2, Yi Wang1,2, Jianhong Gu1,2, Xuezhong Liu1,2, Jianchun Bian1,2, Zongping Liu3,4.
Abstract
Cadmium (Cd) is a toxic metal capable of damaging brain. Studies have demonstrated that Cd can induce apoptosis in neuronal cells. The CD95/APO-1 (Fas)/Fas Ligand (FasL) signaling pathway is one of the primary apoptosis pathways, but the role and regulatory mechanism of this pathway in neuronal cells remain unclear. Here, we demonstrated the underlying mechanism of the Fas/FasL system involving the mitochondrial apoptotic pathway in neuronal cells. Primary rat cerebral cortical neurons and PC12 cells were exposed to Cd, which significantly activated expression of Fas, FasL, Fas-associated death domain (FADD) and cleaved caspase-8. However, expression of cleaved caspase-8 decreased at 20 µM Cd in primary cerebral cortical neurons. Importantly, Cd-induced apoptotic morphological changes and increase in the apoptosis rate were partially blocked by Z-IETD-FMK, which is a specific inhibitor of caspase-8. Cd-mediated increase of apoptosis rate was inhibited by anti-FasL antibody. Furthermore, our data revealed that Z-IETD-FMK also blocked increase of truncated BH3 interacting domain death agonist (tBID)/BID, decrease of the B-cell lymphoma 2 (Bcl-2)/Bcl-2 associate X protein (Bax) ratio and mitochondrial membrane potential (MMP), release of cytochrome c, as well as cleavage of caspase-9/3 and poly (ADP-ribose) polymerase (PARP) induced by Cd. Taken together, our results demonstrate that the Fas/FasL-mediated mitochondrial apoptotic pathway plays an important role in Cd-induced neuronal apoptosis.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29891925 PMCID: PMC5995901 DOI: 10.1038/s41598-018-27106-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Cd activates the Fas/FasL apoptotic signaling pathway in neuronal cells. Primary rat cerebral cortical neurons and PC12 cells incubated with Cd (0, 5, 10, or 20 µM) for 24 h (A), or with Cd (10 µM) for 0, 6, 12, or 24 h (B) were harvested, Fas, FasL, FADD, and cleaved caspase-8 protein levels were assessed by western blot analysis using the relevant antibodies. Blots for Fas, FasL, FADD and cleaved caspase-8 were semi-quantified using Image LabTM software. β-actin was used as internal control. Similar results were observed in at least three independent experiments. Data are expressed as mean ± SD (n = 3) relative to control. *P < 0.05 and **P < 0.01.
Figure 2Z-IETD-FMK partially prevents Cd-induced apoptotic morphological changes of neuronal cells. Primary rat cerebral cortical neurons and PC12 cells were pretreated with or without Z-IETD-FMK (40 µM) for 30 min and then exposed to Cd (10 μM) for 24 h. Apoptotic morphological changes of neuronal cells were visualized by fluorescence microscope after Hoechst 33258 staining. Apoptotic cells are indicated by arrows. The original magnification was 200×. Data are expressed as mean ± SD (n = 3). **P < 0.01.
Figure 3Z-IETD-FMK and anti-FasL antibody partially inhibited Cd-induced apoptosis. (A) Primary rat cerebral cortical neurons and PC12 cells were pretreated with Z-IETD-FMK (40 µM) for 30 min prior to treatment with Cd (10 μM) for 24 h. After staining with annexin V-FITC, fluorescence microscopy analysis of neuronal cells was performed with a DMI3000 B inverted phase microscope at 200× magnifications using FITC and bright field filters. PC12 cells were pretreated with (B) Z-IETD-FMK (40 µM) or (C) anti-FasL (10 mg/L) for 30 min prior to treatment with Cd (10 μM) for 24 h. Following annexin V-FITC and PI double staining, the apoptosis rate of PC12 cells was analyzed by flow cytometry. A representative experimental result is shown. The apoptosis rate was calculated and analyzed using early apoptotic (Q4) and late apoptotic (Q2) cells. Data are expressed as mean ± SD (n = 3). **P < 0.01.
Figure 4Z-IETD-FMK partially blocks Cd-induced upregulation of tBID/BID, reduction of the Bcl-2/Bax ratio in neuronal cells. Primary rat cerebral cortical neurons and PC12 cells were pretreated with Z-IETD-FMK (40 µM) for 30 min prior to treatment with Cd (10 μM) for 24 h. (A) BID and tBID levels and (B) Bcl-2 and Bax levels were determined by western blot using the relevant antibodies. Blots for BID and tBID levels (A) and Bcl-2 and Bax levels (B) in primary neurons and PC12 cells were semi-quantified using Image LabTM software. β-actin was used as an internal control. Data are expressed as mean ± SD (n = 3). *P < 0.05 and **P < 0.01.
Figure 5Z-IETK-FMK blocks the decrease in mitochondrial membrane potential (MMP) induced by Cd in neuronal cells. After a 30 min pretreatment with or without Z-IETD-FMK (40 µM), primary rat cerebral cortical neurons and PC12 cells were treated with Cd (10 µM) for 24 h and assayed for MMP by JC-1 staining. Red fluorescence represents the aggregate form (polymer) of JC-1, indicating normal MMP. Green fluorescence represents the monomeric form of JC-1, indicating a decreased MMP. MMP was visualized by a fluorescence microscope and representative images are shown.
Figure 6Z-IETD-FMK attenuates Cd-induced cytochrome c release and caspase-9/3, and PARP cleavage in neuronal cells. Primary rat cerebral cortical neurons and PC12 cells were pretreated with Z-IETD-FMK (40 µM) for 30 min prior to treatment with Cd (10 μM) for 24 h. (A) The levels of cytosolic cytochrome c (cyto-CytC) and mitochondrial cytochrome c (mito-CytC)) and (B) caspase-9, caspase-3, and PARP cleavage were determined by western blot using the relevant antibodies. Cyclooxygenase IV (COX-IV) and β-actin were used as internal controls for the mitochondrial and cytosolic subfractions, respectively. Blots for cytochrome c and caspase-9/3, and PARP cleavage were semi-quantified using Image LabTM software. Data are expressed as mean ± SD (n = 3). **P < 0.01.